As Nodal has been shown to promote aggressive breast cancer phenotypes and as Nodal knockdown has been shown to reduce tumor incidence and blunt tumor growth in animal models of human breast cancer [8, 10, 11], we undertook to identify and develop a Nodal antagonist that could potentially inhibit Nodal in breast cancers. This evidence concerns the gene NODAL and breast carcinoma.